ICON experts frequently author or contribute to industry trade press. The following are some recent articles.
Five common literature reviews for RWE generation
A discussion of five popular types of RWE literature reviews, including timing, strengths, limitations and applications.
ICON launches Coronavirus Observatory
This article discusses ICON’s Coronavirus Observatory, a tool providing real-time updates on COVID-19 vaccine trials, and insights into key issues.
The Home Depot, the TJX Companies and ICON PLC: Three safe stocks in a stormy market
An article highlighting three safe stocks to buy that have been largely unaffected by market turmoil due to COVID-19.
Role of data in revolutionising the CRO industry
Role of data in revolutionising the CRO industry and the steps that still need to be taken to better match patients with targeted therapies and improve health outcomes.
Fast vs. Formulated
An article published by PharmTech.com which features expert commentary from ICON's VP of Drug Development and Consulting, Stuart Madden.
Seeking early answers to formulation questions
ICON's Stuart Madden provides expert commentary on drug development in this March 2020 BioPharm International article.
Mapping the patient journey and minding the gap
An article featuring commentary by Gretchen Goller which highlights seven steps to closing the gap between rhetoric and reality in patient-centricity.
Bringing the trial to the patient
A thought leadership piece by Gretchen Goller looking into how reducing the burden that clinical trial participation places on patients can help to keep patients engaged in clinical research.
Data management landscape is still changing, are we adapting fast enough?
A thought leadership article authored by Rona O’Donnell centred around the changing nature of clinical data management.
The Significant Role of a Robust Regulatory Intelligence Process in Global Safety Submissions
A thought leadership article on pharmacovigilance, written by Arinder Sihota and Trupti Gurjar, which featured in the March 2020 edition of Pharma Focus.